Company / SG&A per Share
OCULAR THERAPEUTIX, INC SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.41
FY2025
5-year range
$0.29 / $0.53
FY2021-FY2025
Trend
-22.6%
vs FY2024
Sector context
#177 of 210
Health Care
What the data says
OCULAR THERAPEUTIX, INC's sg&a per share of $0.41 is lower than 84% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $0.29 in FY2021 to $0.63 in FY2018.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of -1.5%.
Improved from $0.44 to $0.41 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- -1.5%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 210This company $0.41 Sector average $29.50
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 22.6% year-over-year.
- Ranks #177 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | -22.6% |
| FY2024 | $0.53 | +20.0% |
| FY2023 | $0.44 | +47.6% |
| FY2022 | $0.30 | +2.3% |
| FY2021 | $0.29 | -33.8% |
| FY2020 | $0.44 | +17.7% |
| FY2019 | $0.37 | -41.0% |
| FY2018 | $0.63 | +2.2% |
| FY2017 | $0.62 | +39.4% |
| FY2016 | $0.44 | +438.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026